Skip to main content
Clinical Trials/NCT07751146
NCT07751146Not yet recruitingNot Applicable

Effect of Single-Injection Peripheral Nerve Block on Perioperative Myocardial Injury in Elderly Patients Undergoing Delayed Hip Fracture Surgery: A Single-Center Retrospective Cohort Study

Tongji Hospital0 sites500 target enrollmentStarted: July 15, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
500
Primary Endpoint
The incidence of myocardial injury during the postoperative hospital stay

Study Overview

Brief Summary

This single-center, retrospective cohort study evaluates whether a single preoperative peripheral nerve block can reduce the risk of perioperative myocardial injury in elderly patients undergoing delayed hip fracture surgery, defined as surgery performed more than 48 hours after injury.

Hip fracture is a serious and common injury in older adults worldwide. When surgery cannot be performed within the recommended 48-hour window, patients face a much higher risk of heart muscle damage (myocardial injury), which is strongly linked to increased complications and death. Peripheral nerve blocks are a standard, safe method for pain control in hip fracture care, but their potential protective effect on the heart has not been specifically studied in patients with delayed surgery.

This study will review medical records of patients aged 65 years and older who received hip fracture surgery at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, between January 1, 2019 and December 31, 2025, with time from injury to surgery longer than 48 hours. Patients who received a single peripheral nerve block before surgery will be compared with patients who did not receive any peripheral nerve block.

The main measure of the study is the rate of myocardial injury during hospital stay, detected by elevated troponin levels in routine blood tests. The study will also examine new-onset myocardial injury within 72 hours after surgery, major heart-related adverse events and all-cause death within 30 days after surgery, length of hospital stay, and other common postoperative complications. Researchers will also explore whether the timing of nerve block placement and different block techniques have different heart-protective effects.

The findings may provide evidence for a simple, safe and practical strategy to reduce heart complications in older hip fracture patients who cannot receive timely surgery, and help clinicians improve perioperative care for this high-risk population.

Detailed Description

Study Rationale and Background Hip fracture represents a major public health burden among aging populations worldwide, with rapidly rising incidence driven by global demographic shifts. In older adults, hip fracture is associated with substantially elevated morbidity and mortality, with 1-year mortality rates reaching 20-30% even after surgical treatment. Current clinical guidelines uniformly recommend surgery within 48 hours of injury as the standard of care to improve outcomes. However, delayed surgery - defined as surgery performed more than 48 hours after injury - remains highly prevalent globally, particularly in resource-limited settings, affecting up to 60-80% of patients in some regions.

Accumulating evidence demonstrates that delayed surgery is associated with a dose-dependent increase in postoperative complications and mortality, with each 24-hour delay linked to a 12% higher risk of major adverse cardiovascular events (MACE) and a 5% relative increase in 30-day mortality. A key mediator of this elevated risk is perioperative myocardial injury, also termed myocardial injury after noncardiac surgery (MINS). MINS is defined as troponin elevation above the 99th percentile upper reference limit attributable to ischemic mechanisms, and it is one of the most common serious perioperative complications in older surgical patients. In hip fracture populations, the incidence of myocardial injury is particularly high, and it is strongly associated with short- and long-term mortality. The elevated cardiac risk in delayed surgery is driven primarily by sustained severe pain leading to sympathetic overactivation, heightened systemic inflammation, hypercoagulability, and physiological stress from prolonged preoperative immobilization.

Peripheral nerve block (PNB) is the gold standard for perioperative pain management in hip fracture, strongly recommended by international anesthesiology and orthopedic guidelines. Ultrasound-guided PNB techniques, including pericapsular nerve group (PENG) block, fascia iliaca compartment block, and femoral nerve block, provide effective analgesia and reduce opioid consumption. A recent landmark two-center cohort study published in Anesthesiology in 2026 found that preoperative single-injection PNB reduced the risk of postoperative myocardial injury by 40% in high-risk older adults undergoing hip fracture surgery.

Nevertheless, critical evidence gaps remain. The prior study included a mixed population of both early and delayed surgery patients, and did not specifically evaluate the cardiac protective effect of PNB in the delayed surgery subgroup - a population at markedly higher baseline cardiac risk. It also did not distinguish preoperatively existing myocardial injury from new-onset postoperative injury, nor did it examine the potential impact of block timing or different block techniques on cardiac outcomes. It remains unknown whether PNB still confers cardiac benefit in patients who have already sustained prolonged pain and stress from delayed surgery, and whether it can attenuate progression of myocardial injury in patients with preoperatively elevated troponin.

Study Objectives This single-center retrospective cohort study aims to investigate the effect of preoperative single-injection peripheral nerve block on perioperative myocardial injury in older patients undergoing delayed hip fracture surgery (time from injury to surgery > 48 hours).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 65 years
  • Radiological evidence of non-pathological hip fractures (femoral neck, intertrochanteric or subtrochanteric fractures)
  • Time from injury to surgery > 48 hours
  • Underwent general anesthesia or intraspinal anesthesia
  • Had at least one troponin I/T test result during preoperative or postoperative hospitalization

Exclusion Criteria

  • Preoperative presence of acute myocardial infarction (onset < 7 days), acute heart failure or sepsis
  • Multiple fractures or concurrent surgeries at other sites
  • Neuroblock as the sole anesthesia method
  • Continuous nerve block or epidural analgesia
  • Severe lack of key variables

Arms & Interventions

Non-PNB group

Not receiving any peripheral nerve block

Intervention: Non-PNB (Procedure)

PNB group

Received a single peripheral nerve block (PENG block / iliac fascial space block / femoral nerve block / lumbar plexus block) before the operation

Intervention: PNB (Procedure)

Outcomes

Primary Outcomes

The incidence of myocardial injury during the postoperative hospital stay

Time Frame: Before the operation, 24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation

It is defined as any time after surgery when the level of troponin I/T exceeds the 99th percentile reference upper limit, which is exactly the same as the original definition in the 2026 "Anesthesiology" study.

Secondary Outcomes

  • The incidence of new myocardial injury within 72 hours after the operation(Before the operation, 24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation)
  • The magnitude of the increase in postoperative troponin levels compared to the baseline in patients with elevated troponin levels before the operation(The amplitude of the increase in postoperative troponin levels compared to the baseline in patients with elevated troponin levels before the operation at 24 hours, 48 hours, 72 hours, at discharge (up to 2 weeks) and 30 days after the operation.)
  • The area under the curve of the peak value and dynamic changes of troponin(The area under the curve of peak troponin levels and their dynamic changes before surgery, 24 hours after surgery, 48 hours after surgery, 72 hours after surgery; at discharge (up to 2 weeks); and 30 days after surgery)
  • 30 days after the surgery, the incidence of major adverse cardiovascular events (MACE) and all-cause mortality(30 days after the operation)
  • ICU admission(24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation)
  • The type of blocking techniques(During the operation)
  • The interaction between preoperative troponin status and the efficacy of nerve block(Before the operation, 24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation)
  • Hospital stay(24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation)
  • Other adverse effects(24 hours after the operation, 48 hours after the operation, 72 hours after the operation; at discharge (up to 2 weeks); 30 days after the operation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tianzhu Liu

M.D.

Tongji Hospital

Similar Trials